These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 2428564)
1. Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I. Guldner HH; Szostecki C; Vosberg HP; Lakomek HJ; Penner E; Bautz FA Chromosoma; 1986; 94(2):132-8. PubMed ID: 2428564 [TBL] [Abstract][Full Text] [Related]
2. Anti-topoisomerase I autoantibodies in systemic sclerosis. Czömpöly T; Simon D; Czirják L; Németh P Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194 [TBL] [Abstract][Full Text] [Related]
3. Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion. Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski T; Jabłońska S; Maul GG Arch Dermatol Res; 1990; 282(2):76-83. PubMed ID: 2162156 [TBL] [Abstract][Full Text] [Related]
4. Specificity of anti-Scl-70 antibodies in scleroderma: increased sensitivity of detection using purified DNA topoisomerase I from calf thymus. Tsay GJ; Fann RH; Hwang J J Rheumatol; 1990 Oct; 17(10):1314-9. PubMed ID: 2174971 [TBL] [Abstract][Full Text] [Related]
5. Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis. Maul GG; Jimenez SA; Riggs E; Ziemnicka-Kotula D Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8492-6. PubMed ID: 2479024 [TBL] [Abstract][Full Text] [Related]
6. Redefining the Scl-70 indirect immunofluorescence pattern: autoantibodies to DNA topoisomerase I yield a specific compound immunofluorescence pattern. Dellavance A; Gallindo C; Soares MG; da Silva NP; Mortara RA; Andrade LE Rheumatology (Oxford); 2009 Jun; 48(6):632-7. PubMed ID: 19395540 [TBL] [Abstract][Full Text] [Related]
7. Plant DNA topoisomerase I is recognized and inhibited by human Scl-70 sera autoantibodies. Agris PF; Parks R; Bowman L; Guenther RH; Kovacs SA; Pelsue S Exp Cell Res; 1990 Aug; 189(2):276-9. PubMed ID: 2164485 [TBL] [Abstract][Full Text] [Related]
8. Use of molecular cloning methods to map the distribution of epitopes on topoisomerase I (Scl-70) recognized by sera of scleroderma patients. D'Arpa P; White-Cooper H; Cleveland DW; Rothfield NF; Earnshaw WC Arthritis Rheum; 1990 Oct; 33(10):1501-11. PubMed ID: 1699543 [TBL] [Abstract][Full Text] [Related]
9. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Shero JH; Bordwell B; Rothfield NF; Earnshaw WC Science; 1986 Feb; 231(4739):737-40. PubMed ID: 3003910 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of topoisomerase I by antibodies in sera from scleroderma patients. Samuels DS; Tojo T; Homma M; Shimizu N FEBS Lett; 1986 Dec; 209(2):231-4. PubMed ID: 2431927 [TBL] [Abstract][Full Text] [Related]
11. Topoisomerase I identified by scleroderma 70 antisera: enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase. Maul GG; French BT; van Venrooij WJ; Jimenez SA Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5145-9. PubMed ID: 3014535 [TBL] [Abstract][Full Text] [Related]
12. Antibodies to topoisomerase I in sera from patients with scleroderma. Shero JH; Bordwell B; Rothfield NF; Earnshaw WC J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():138-40. PubMed ID: 3039129 [TBL] [Abstract][Full Text] [Related]
14. Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma). Shoenfeld Y; Grunebaum E; Laufer M; Zurgil N; Bakimer R; Lunderschmidt A; Valentini G; Tirri G; Blank M Isr J Med Sci; 1996 Jul; 32(7):537-42. PubMed ID: 8756980 [TBL] [Abstract][Full Text] [Related]
15. An antigenic region of topoisomerase I in DNA polymerase chain reaction-generated fragments recognized by autoantibodies of scleroderma patients. Piccinini G; Cardellini E; Reimer G; Arnett FC; Durban E Mol Immunol; 1991; 28(4-5):333-9. PubMed ID: 1712070 [TBL] [Abstract][Full Text] [Related]
16. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238 [TBL] [Abstract][Full Text] [Related]
17. Anti-RNA polymerase antibodies in systemic sclerosis (SSc): association with anti-topoisomerase I antibodies and identification of autoreactive subunits of RNA polymerase II. Harvey GR; Rands AL; McHugh NJ Clin Exp Immunol; 1996 Sep; 105(3):468-74. PubMed ID: 8809136 [TBL] [Abstract][Full Text] [Related]
18. Anti-NOR 90. A new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolus-organizing region of chromatin. Rodriguez-Sanchez JL; Gelpi C; Juarez C; Hardin JA J Immunol; 1987 Oct; 139(8):2579-84. PubMed ID: 3309055 [TBL] [Abstract][Full Text] [Related]
19. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins. Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017 [TBL] [Abstract][Full Text] [Related]
20. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients. Hénault J; Robitaille G; Senécal JL; Raymond Y Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]